EMEA (Europe, Middle East and Africa) Prosthetic Joint Infections Treatment Market Report 2018

January 2018 | 108 pages | ID: E3111A38E4EEN
QYResearch

Abstracts

In this report, the EMEA Prosthetic Joint Infections Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Prosthetic Joint Infections Treatment for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Prosthetic Joint Infections Treatment market competition by top manufacturers/players, with Prosthetic Joint Infections Treatment sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Cempra Inc
• Motif Bio Plc
• Nabriva Therapeutics AG
• Telephus Medical LLC
• TenNor Therapeutics Ltd

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Fusidic acid
• Lefamulin Acetate
• MTF-101
• TNP-2092
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Clinic
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Prosthetic Joint Infections Treatment Market Report 2017

1 PROSTHETIC JOINT INFECTIONS TREATMENT OVERVIEW

1.1 Product Overview and Scope of Prosthetic Joint Infections Treatment
1.2 Classification of Prosthetic Joint Infections Treatment
  1.2.1 EMEA Prosthetic Joint Infections Treatment Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Prosthetic Joint Infections Treatment Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Fusidic acid
  1.2.4 Lefamulin Acetate
  1.2.5 MTF-101
  1.2.6 TNP-2092
  1.2.7 Others
1.3 EMEA Prosthetic Joint Infections Treatment Market by Application/End Users
  1.3.1 EMEA Prosthetic Joint Infections Treatment Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Others
1.4 EMEA Prosthetic Joint Infections Treatment Market by Region
  1.4.1 EMEA Prosthetic Joint Infections Treatment Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Prosthetic Joint Infections Treatment (2012-2022)
  1.5.1 EMEA Prosthetic Joint Infections Treatment Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Prosthetic Joint Infections Treatment Revenue and Growth Rate (2012-2022)

2 EMEA PROSTHETIC JOINT INFECTIONS TREATMENT COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Prosthetic Joint Infections Treatment Market Competition by Players/Manufacturers
  2.1.1 EMEA Prosthetic Joint Infections Treatment Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Prosthetic Joint Infections Treatment Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Prosthetic Joint Infections Treatment Sale Price by Players (2012-2017)
2.2 EMEA Prosthetic Joint Infections Treatment (Volume and Value) by Type/Product Category
  2.2.1 EMEA Prosthetic Joint Infections Treatment Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Prosthetic Joint Infections Treatment Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Prosthetic Joint Infections Treatment Sale Price by Type (2012-2017)
2.3 EMEA Prosthetic Joint Infections Treatment (Volume) by Application
2.4 EMEA Prosthetic Joint Infections Treatment (Volume and Value) by Region
  2.4.1 EMEA Prosthetic Joint Infections Treatment Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Prosthetic Joint Infections Treatment Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Prosthetic Joint Infections Treatment Sales Price by Region (2012-2017)

3 EUROPE PROSTHETIC JOINT INFECTIONS TREATMENT (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Prosthetic Joint Infections Treatment Sales and Value (2012-2017)
  3.1.1 Europe Prosthetic Joint Infections Treatment Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Prosthetic Joint Infections Treatment Revenue and Growth Rate (2012-2017)
3.2 Europe Prosthetic Joint Infections Treatment Sales and Market Share by Type
3.3 Europe Prosthetic Joint Infections Treatment Sales and Market Share by Application
3.4 Europe Prosthetic Joint Infections Treatment Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Prosthetic Joint Infections Treatment Sales Volume by Countries (2012-2017)
  3.4.2 Europe Prosthetic Joint Infections Treatment Revenue by Countries (2012-2017)
  3.4.3 Germany Prosthetic Joint Infections Treatment Sales and Growth Rate (2012-2017)
  3.4.4 France Prosthetic Joint Infections Treatment Sales and Growth Rate (2012-2017)
  3.4.5 UK Prosthetic Joint Infections Treatment Sales and Growth Rate (2012-2017)
  3.4.6 Russia Prosthetic Joint Infections Treatment Sales and Growth Rate (2012-2017)
  3.4.7 Italy Prosthetic Joint Infections Treatment Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Prosthetic Joint Infections Treatment Sales and Growth Rate (2012-2017)

4 MIDDLE EAST PROSTHETIC JOINT INFECTIONS TREATMENT (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Prosthetic Joint Infections Treatment Sales and Value (2012-2017)
  4.1.1 Middle East Prosthetic Joint Infections Treatment Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Prosthetic Joint Infections Treatment Revenue and Growth Rate (2012-2017)
4.2 Middle East Prosthetic Joint Infections Treatment Sales and Market Share by Type
4.3 Middle East Prosthetic Joint Infections Treatment Sales and Market Share by Application
4.4 Middle East Prosthetic Joint Infections Treatment Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Prosthetic Joint Infections Treatment Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Prosthetic Joint Infections Treatment Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Prosthetic Joint Infections Treatment Sales and Growth Rate (2012-2017)
  4.4.4 Israel Prosthetic Joint Infections Treatment Sales and Growth Rate (2012-2017)
  4.4.5 UAE Prosthetic Joint Infections Treatment Sales and Growth Rate (2012-2017)
  4.4.6 Iran Prosthetic Joint Infections Treatment Sales and Growth Rate (2012-2017)

5 AFRICA PROSTHETIC JOINT INFECTIONS TREATMENT (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Prosthetic Joint Infections Treatment Sales and Value (2012-2017)
  5.1.1 Africa Prosthetic Joint Infections Treatment Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Prosthetic Joint Infections Treatment Revenue and Growth Rate (2012-2017)
5.2 Africa Prosthetic Joint Infections Treatment Sales and Market Share by Type
5.3 Africa Prosthetic Joint Infections Treatment Sales and Market Share by Application
5.4 Africa Prosthetic Joint Infections Treatment Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Prosthetic Joint Infections Treatment Sales Volume by Countries (2012-2017)
  5.4.2 Africa Prosthetic Joint Infections Treatment Revenue by Countries (2012-2017)
  5.4.3 South Africa Prosthetic Joint Infections Treatment Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Prosthetic Joint Infections Treatment Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Prosthetic Joint Infections Treatment Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Prosthetic Joint Infections Treatment Sales and Growth Rate (2012-2017)

6 EMEA PROSTHETIC JOINT INFECTIONS TREATMENT MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Cempra Inc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Prosthetic Joint Infections Treatment Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Cempra Inc Prosthetic Joint Infections Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Motif Bio Plc
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Prosthetic Joint Infections Treatment Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Motif Bio Plc Prosthetic Joint Infections Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Nabriva Therapeutics AG
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Prosthetic Joint Infections Treatment Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Telephus Medical LLC
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Prosthetic Joint Infections Treatment Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Telephus Medical LLC Prosthetic Joint Infections Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 TenNor Therapeutics Ltd
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Prosthetic Joint Infections Treatment Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview

7 PROSTHETIC JOINT INFECTIONS TREATMENT MANUFACTURING COST ANALYSIS

7.1 Prosthetic Joint Infections Treatment Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Prosthetic Joint Infections Treatment

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Prosthetic Joint Infections Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Prosthetic Joint Infections Treatment Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA PROSTHETIC JOINT INFECTIONS TREATMENT MARKET FORECAST (2017-2022)

11.1 EMEA Prosthetic Joint Infections Treatment Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Prosthetic Joint Infections Treatment Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Prosthetic Joint Infections Treatment Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Prosthetic Joint Infections Treatment Price and Trend Forecast (2017-2022)
11.2 EMEA Prosthetic Joint Infections Treatment Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Prosthetic Joint Infections Treatment Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Prosthetic Joint Infections Treatment Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Prosthetic Joint Infections Treatment Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Prosthetic Joint Infections Treatment Sales Forecast by Type (2017-2022)
11.7 EMEA Prosthetic Joint Infections Treatment Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Prosthetic Joint Infections Treatment
Figure EMEA Prosthetic Joint Infections Treatment Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Prosthetic Joint Infections Treatment Sales Volume Market Share by Type (Product Category) in 2016
Figure Fusidic acid Product Picture
Figure Lefamulin Acetate Product Picture
Figure MTF-101 Product Picture
Figure TNP-2092 Product Picture
Figure Others Product Picture
Figure EMEA Prosthetic Joint Infections Treatment Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Prosthetic Joint Infections Treatment by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Prosthetic Joint Infections Treatment Market Size (Million USD) by Region (2012-2022)
Figure Europe Prosthetic Joint Infections Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Prosthetic Joint Infections Treatment Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Prosthetic Joint Infections Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Prosthetic Joint Infections Treatment Revenue (Million USD) Status and Forecast by Countries
Figure Africa Prosthetic Joint Infections Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Prosthetic Joint Infections Treatment Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Prosthetic Joint Infections Treatment Sales Volume and Growth Rate (2012-2022)
Figure EMEA Prosthetic Joint Infections Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Prosthetic Joint Infections Treatment Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Prosthetic Joint Infections Treatment Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Prosthetic Joint Infections Treatment Sales Share by Players (2012-2017)
Figure 2016 Prosthetic Joint Infections Treatment Sales Share by Players
Figure 2017 Prosthetic Joint Infections Treatment Sales Share by Players
Figure EMEA Prosthetic Joint Infections Treatment Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Prosthetic Joint Infections Treatment Revenue (Million USD) by Players (2012-2017)
Table EMEA Prosthetic Joint Infections Treatment Revenue Share by Players (2012-2017)
Table 2016 EMEA Prosthetic Joint Infections Treatment Revenue Share by Players
Table 2017 EMEA Prosthetic Joint Infections Treatment Revenue Share by Players
Table EMEA Prosthetic Joint Infections Treatment Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Prosthetic Joint Infections Treatment Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Prosthetic Joint Infections Treatment Sales Share by Type (2012-2017)
Figure Sales Market Share of Prosthetic Joint Infections Treatment by Type (2012-2017)
Figure EMEA Prosthetic Joint Infections Treatment Sales Market Share by Type (2012-2017)
Table EMEA Prosthetic Joint Infections Treatment Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Prosthetic Joint Infections Treatment Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Prosthetic Joint Infections Treatment by Type in 2016
Table EMEA Prosthetic Joint Infections Treatment Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Prosthetic Joint Infections Treatment Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Prosthetic Joint Infections Treatment Sales Share by Application (2012-2017)
Figure Sales Market Share of Prosthetic Joint Infections Treatment by Application (2012-2017)
Figure EMEA Prosthetic Joint Infections Treatment Sales Market Share by Application in 2016
Table EMEA Prosthetic Joint Infections Treatment Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Prosthetic Joint Infections Treatment Sales Share by Region (2012-2017)
Figure Sales Market Share of Prosthetic Joint Infections Treatment by Region (2012-2017)
Figure EMEA Prosthetic Joint Infections Treatment Sales Market Share in 2016
Table EMEA Prosthetic Joint Infections Treatment Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Prosthetic Joint Infections Treatment Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Prosthetic Joint Infections Treatment by Region (2012-2017)
Figure EMEA Prosthetic Joint Infections Treatment Revenue Market Share Regions in 2016
Table EMEA Prosthetic Joint Infections Treatment Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Prosthetic Joint Infections Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Prosthetic Joint Infections Treatment Revenue and Growth Rate (2012-2017)
Table Europe Prosthetic Joint Infections Treatment Sales (K Pcs) by Type (2012-2017)
Table Europe Prosthetic Joint Infections Treatment Market Share by Type (2012-2017)
Figure Europe Prosthetic Joint Infections Treatment Market Share by Type in 2016
Table Europe Prosthetic Joint Infections Treatment Sales (K Pcs) by Application (2012-2017)
Table Europe Prosthetic Joint Infections Treatment Market Share by Application (2012-2017)
Figure Europe Prosthetic Joint Infections Treatment Market Share by Application in 2016
Table Europe Prosthetic Joint Infections Treatment Sales (K Pcs) by Countries (2012-2017)
Table Europe Prosthetic Joint Infections Treatment Sales Market Share by Countries (2012-2017)
Figure Europe Prosthetic Joint Infections Treatment Sales Market Share by Countries (2012-2017)
Figure Europe Prosthetic Joint Infections Treatment Sales Market Share by Countries in 2016
Table Europe Prosthetic Joint Infections Treatment Revenue (Million USD) by Countries (2012-2017)
Table Europe Prosthetic Joint Infections Treatment Revenue Market Share by Countries (2012-2017)
Figure Europe Prosthetic Joint Infections Treatment Revenue Market Share by Countries (2012-2017)
Figure Europe Prosthetic Joint Infections Treatment Revenue Market Share by Countries in 2016
Figure Germany Prosthetic Joint Infections Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Prosthetic Joint Infections Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Prosthetic Joint Infections Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Prosthetic Joint Infections Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Prosthetic Joint Infections Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Prosthetic Joint Infections Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Prosthetic Joint Infections Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Prosthetic Joint Infections Treatment Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Prosthetic Joint Infections Treatment Sales (K Pcs) by Type (2012-2017)
Table Middle East Prosthetic Joint Infections Treatment Market Share by Type (2012-2017)
Figure Middle East Prosthetic Joint Infections Treatment Market Share by Type (2012-2017)
Table Middle East Prosthetic Joint Infections Treatment Sales (K Pcs) by Applications (2012-2017)
Table Middle East Prosthetic Joint Infections Treatment Market Share by Applications (2012-2017)
Figure Middle East Prosthetic Joint Infections Treatment Sales Market Share by Application in 2016
Table Middle East Prosthetic Joint Infections Treatment Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Prosthetic Joint Infections Treatment Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Prosthetic Joint Infections Treatment Sales Volume Market Share by Countries in 2016
Table Middle East Prosthetic Joint Infections Treatment Revenue (Million USD) by Countries (2012-2017)
Table Middle East Prosthetic Joint Infections Treatment Revenue Market Share by Countries (2012-2017)
Figure Middle East Prosthetic Joint Infections Treatment Revenue Market Share by Countries (2012-2017)
Figure Middle East Prosthetic Joint Infections Treatment Revenue Market Share by Countries in 2016
Figure Saudi Arabia Prosthetic Joint Infections Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Prosthetic Joint Infections Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Prosthetic Joint Infections Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Prosthetic Joint Infections Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Prosthetic Joint Infections Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Prosthetic Joint Infections Treatment Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Prosthetic Joint Infections Treatment Sales (K Pcs) by Type (2012-2017)
Table Africa Prosthetic Joint Infections Treatment Sales Market Share by Type (2012-2017)
Figure Africa Prosthetic Joint Infections Treatment Sales Market Share by Type (2012-2017)
Figure Africa Prosthetic Joint Infections Treatment Sales Market Share by Type in 2016
Table Africa Prosthetic Joint Infections Treatment Sales (K Pcs) by Application (2012-2017)
Table Africa Prosthetic Joint Infections Treatment Sales Market Share by Application (2012-2017)
Figure Africa Prosthetic Joint Infections Treatment Sales Market Share by Application (2012-2017)
Table Africa Prosthetic Joint Infections Treatment Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Prosthetic Joint Infections Treatment Sales Market Share by Countries (2012-2017)
Figure Africa Prosthetic Joint Infections Treatment Sales Market Share by Countries (2012-2017)
Figure Africa Prosthetic Joint Infections Treatment Sales Market Share by Countries in 2016
Table Africa Prosthetic Joint Infections Treatment Revenue (Million USD) by Countries (2012-2017)
Table Africa Prosthetic Joint Infections Treatment Revenue Market Share by Countries (2012-2017)
Figure Africa Prosthetic Joint Infections Treatment Revenue Market Share by Countries (2012-2017)
Figure Africa Prosthetic Joint Infections Treatment Revenue Market Share by Countries in 2016
Figure South Africa Prosthetic Joint Infections Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Prosthetic Joint Infections Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Prosthetic Joint Infections Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Prosthetic Joint Infections Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Table Cempra Inc Prosthetic Joint Infections Treatment Basic Information List
Table Cempra Inc Prosthetic Joint Infections Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Cempra Inc Prosthetic Joint Infections Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Cempra Inc Prosthetic Joint Infections Treatment Sales Market Share in EMEA (2012-2017)
Figure Cempra Inc Prosthetic Joint Infections Treatment Revenue Market Share in EMEA (2012-2017)
Table Motif Bio Plc Prosthetic Joint Infections Treatment Basic Information List
Table Motif Bio Plc Prosthetic Joint Infections Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Motif Bio Plc Prosthetic Joint Infections Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Motif Bio Plc Prosthetic Joint Infections Treatment Sales Market Share in EMEA (2012-2017)
Figure Motif Bio Plc Prosthetic Joint Infections Treatment Revenue Market Share in EMEA (2012-2017)
Table Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Basic Information List
Table Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Sales Market Share in EMEA (2012-2017)
Figure Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Revenue Market Share in EMEA (2012-2017)
Table Telephus Medical LLC Prosthetic Joint Infections Treatment Basic Information List
Table Telephus Medical LLC Prosthetic Joint Infections Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Telephus Medical LLC Prosthetic Joint Infections Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Telephus Medical LLC Prosthetic Joint Infections Treatment Sales Market Share in EMEA (2012-2017)
Figure Telephus Medical LLC Prosthetic Joint Infections Treatment Revenue Market Share in EMEA (2012-2017)
Table TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Basic Information List
Table TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Sales Market Share in EMEA (2012-2017)
Figure TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prosthetic Joint Infections Treatment
Figure Manufacturing Process Analysis of Prosthetic Joint Infections Treatment
Figure Prosthetic Joint Infections Treatment Industrial Chain Analysis
Table Raw Materials Sources of Prosthetic Joint Infections Treatment Major Manufacturers in 2016
Table Major Buyers of Prosthetic Joint Infections Treatment
Table Distributors/Traders List
Figure EMEA Prosthetic Joint Infections Treatment Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Prosthetic Joint Infections Treatment Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Prosthetic Joint Infections Treatment Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Prosthetic Joint Infections Treatment Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Prosthetic Joint Infections Treatment Sales Market Share Forecast by Region (2017-2022)
Table EMEA Prosthetic Joint Infections Treatment Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Prosthetic Joint Infections Treatment Revenue Market Share Forecast by Region (2017-2022)
Table Europe Prosthetic Joint Infections Treatment Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Prosthetic Joint Infections Treatment Sales Market Share Forecast by Countries (2017-2022)
Table Europe Prosthetic Joint Infections Treatment Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Prosthetic Joint Infections Treatment Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Prosthetic Joint Infections Treatment Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Prosthetic Joint Infections Treatment Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Prosthetic Joint Infections Treatment Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Prosthetic Joint Infections Treatment Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Prosthetic Joint Infections Treatment Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Prosthetic Joint Infections Treatment Sales Market Share Forecast by Countries (2017-2022)
Table Africa Prosthetic Joint Infections Treatment Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Prosthetic Joint Infections Treatment Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Prosthetic Joint Infections Treatment Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Prosthetic Joint Infections Treatment Sales Market Share Forecast by Type (2017-2022)
Table EMEA Prosthetic Joint Infections Treatment Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Prosthetic Joint Infections Treatment Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources